期刊文献+

自发性高血压鼠心脏组织肌球蛋白轻链磷酸酶水平的研究 被引量:4

Study on content of myosin light chain phosphatase of heart in spontaneously hypertensive rats
原文传递
导出
摘要 目的:比较自发性高血压大鼠(SHR)和正常血压大鼠(WKY)心脏组织的心肌肌球蛋白磷酸酶(MLCP)的130000、38000、21000亚单位含量的差异,以探讨MLCP与SHR心脏舒缩机制的关系。方法:在4℃的环境下,取SHR与WKY大鼠各10只断头处死,迅速取其心脏组织,称重速冻后将其磨成匀浆,置于缓冲液中并通过离心提取蛋白质,校正2组总蛋白的浓度后,分别应用SDS-PAGE、Western印迹杂交和化学发光的方法测定SHR与WKY心脏组织MLCP的130000、38000、21000亚单位的含量,对显影结果进一步进行吸光度扫描分析。结果:SHR和WKY大鼠心脏组织的MLCP的亚单位的含量不同,SHR的MLCP的130000、38000、21000亚单位含量均高于WKY大鼠(P<0.01)。结论:SHR与WKY大鼠心脏组织MLCP的130000、38000、21000亚单位含量有着明显的差异,提示心脏组织的MLCP结构或功能的异常可能与SHR高血压的病理机制有关。 Objective: To investigate 130 000,38 000,21 000 subunits content of differential concentration myosin light chain phosphatase (MI.CP) in cardiac muscle between spontaneously hypertensive rat (SHR) and Wistar Kyoto rat (WKY). Method:The hearts were obtained from 10 SHRs and 10 WKY rats. Each tissue was freshly removed and weighed and rapidly frozen in liquid nitrogen. The content of 130 000,38 000,21 000 subunits were determined by SDS PAGE and Western blots. Result:the content of 130 000,38 000,21 000 is different in the cardiac muscle between SHR and WKY. The content of 130 000,38 000,21 000 subunit of SHR is higher than WKY' in the same concentration(P〈0.01). Conclusion: The difference among the contents of 130 000, 38 000 and 21 000 subunit of SHR and WKY show that abnormity of MLCP' structure and function is associated with hy pertension pathomechanism of SHR.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2007年第5期379-382,共4页 Journal of Clinical Cardiology
关键词 高血压 肌球蛋白轻链磷酸酶 心脏 Hypertension Myosin light chain phosphatase Heart
  • 相关文献

参考文献20

  • 1HARTSHORNE D J.Myosin phosphatase:subunits and interactions[J].Acta Physiol Dcand,1998,164:483-493.
  • 2HIRANO K,PHAN B C,HARTSHORNE D J.Interactions of the subunits of smooth muscle myosin phosphatase[J].J Biol Chem,1997,272:3683-3688.
  • 3McAINSH A M,GEYER M,FANDREY J,et al.Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats.Mol Cell Biochem,1998,187:141-146.
  • 4BRADFORD M M.A rapid and sensitive methods for the quantitation of microgran quantities of protein utilizing the principle of protein-dye binding[J].Anal Biochem,1976,72:248-254.
  • 5NISHIKAWA M,TOYODA H,SAITO M.Calyculin A and okadaic acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A[J].Cell Signal,1994,6:59-71.
  • 6PELOUCH V.Molecular aspects of regulation of cardiac contraction[J].Physiol Res,1995,44:53-60.
  • 7ICHIKAWA K,ITO M,HARTSHORNE D J.Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity[J].J Biol Chem,1996,271:4733-4740.
  • 8KIMURA K,ITO M,AMANO M.Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)[J].Science,1996,273:245-248.
  • 9WETTSCHURECK N,OFFERMANNS S.Rho/ Rho-kinase mediated signaling in physiology and pat hophysiology[J].J Mol Med,2002,80:629-638.
  • 10ETIENNE-MANNEVILLE S,HALL A.Rho GTPases in cell biology[J].Nature,2002,420:629-635.

二级参考文献9

  • 1Shen CY,Zhu ZM,Yan ZC et al.High fat plus high salt diet induced metabolic syndrome in Wistar rat.Ame J Hypertension,2004,17(5):513.
  • 2Dvorsky R,Blumenstein L,Vetter IR et al.Structural insights into the interaction of ROCKI with the switch regions of RhoA.J Biol Chem,2004,279(8):7098.
  • 3Hu E,Lee D.Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.Curr Opin Investig Drugs,2003,4(9):1065.
  • 4Sward K,Mita M,Wilson DP et al.The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.Curr Hypertens Rep,2003,5(1):66.
  • 5Lee DL,Webb RC,Jin LM.Hypertension and RhoA/Rho-kinase signaling in the vasculature highlights from the recent literature.Hypertension,2004,44:796.
  • 6Moriki N,Ito M,Seko T et al.RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.Hypertens Res,2004,27(4):263.
  • 7Chitaley K,Webb RC.Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling.Hypertension,2002,39(2 Pt 2):438.
  • 8Fagan KA,Oka M,Bauer NR et al.Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.Am J Physiol Lung Cell Mol Physiol,2004,287(4):L656.
  • 9Zhu ZM,Zhu SJ,Liu DY et al.Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase.Hypertension,2005,45:233.

共引文献2

同被引文献23

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部